Blog: 2017 Prohibited List

13 December 2016

A reminder that the 2017 Prohibited List (the Prohibited List) published by the World Anti-Doping Agency comes into effect on 1 January 2017. 

The Prohibited List, as well as information about major modifications to the list and additions to the monitoring program are available via the WADA website.

It is important for athletes to be aware of changes to the Prohibited List to help protect their health, career and the integrity of their sport. ASADA’s Check Your Substances (Global DRO) online tool will be updated when the changes come into effect.

While most of the changes are simple clarifications or examples, we would like to highlight the addition of the following substances to the Prohibited List for your information:


S2 GATA inhibitors (e.g. K-11706) and Transforming Growth Factor- β (TGF-β) inhibitors (e.g. sotatercept, luspatercept) These substances modify an individual’s blood production.
S6 Lisdexamfetamine It is a stimulant found in Australian medications for the treatment of ADHD. It is an inactive pro-drug of amfetamine.
S7 Nicomorphine It is an opioid analgesic drug, which is converted to morphine following administration.














Further information about anti-doping in Australia is available on this website or by calling 13 000 27232.